General Biologicals
Healthcare Services · Taiwan · 51-200 Employees
View Company Info for Free
Overview
Headquarters
No. 6 Innovation 1st Hsinchu Rd, Hsinchu...Phone Number
+886 35779221Website
www.gbc.com.twRevenue
$6.1 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
2
2
1
2
3
1
About General Biologicals
Founded in 1984, General Biologicals Corporation (GBC) is a Taiwanese leader in precision diagnostics and biotechnology, specializing in in-vitro diagnostics (IVD) and next-generation therapeutics. GBC offers a diverse range of products, including liquid biopsy systems, antimicrobial peptide therapies, and digital healthcare solutions, serving hospitals, clinics, and laboratories in over 40 countries. The company is committed to innovation in precision medicine, focusing on cancer diagnostics and monitoring through its advanced CellBio technology platform. GBC aims to enhance global healthcare by integrating AI and big data into its diagnostic and therapeutic offerings.Explore more
General Biologicals Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is General Biologicals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when General Biologicals launches new products
Check if General Biologicals has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on General Biologicals recently announced quarterly report
Click to see if General Biologicals had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
General Biologicals, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if General Biologicals is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once General Biologicals has new funding data
Congratulate Masked Content for being promoted to Masked Content at General Biologicals
Recommended Actions
Find VP level buyers at General Biologicals
Find more new buyers
Company Profile Activity
Activity Insights
General Biologicals is experiencing very low activity levels compared to other companies in the Healthcare Services sector.
What does this means?
General Biologicals is drawing exceptional interest within the Healthcare Services industry, suggesting notable developments or strong market momentum, learn more about General Biologicals.
General Biologicals Tech Stack
A closer look at the technologies used by General Biologicals
General Biologicals News & Media
General Biologicals Corporation (GBC) and Chairman Lin Tsong-Chin Honored at Asia Pacific Enterprise Awards 2022 Taiwan
SINGAPORE, Jan. 10, 2023 /PRNewswire/ -- The Asia Pacific Enterprise Awards (APEA) 2022 Taiwan is pleased to honor 34 outstanding business leaders and enterprises for their commendable dedication toward spearheading Taiwan's economic recovery and development. Presented by leading regional NGO Enterprise Asia, the APEA is the most reputable award recognition program recognizing entrepreneurial excellence across Asia. The APEA aims to congregate exemplary business leaders and enterprises across AsPacgen Successfully Completes its Plan of Arrangement
VANCOUVER, British Columbia, Sept. 30, 2020 (GLOBE NEWSWIRE) -- Pacgen Life Science Corporation (“Pacgen” or the “Company”) (TSX-V: PBS) is pleased to announce it has completed a statutory plan of arrangement (the "Arrangement") under the Business Corporations Act (British Columbia) pursuant to which General Biologicals Corporation ("GBC") has acquired all of the issued and outstanding common shares of the Company (“Pacgen Shares”), other than Pacgen Shares owned by GBC, its Executive Chairman aPacgen Announces Shareholder Approval of Acquisition by General Biologicals Corporation
VANCOUVER, British Columbia, Sept. 16, 2020 (GLOBE NEWSWIRE) -- Pacgen Life Science Corporation (“Pacgen” or the “Company”) (TSX-V: PBS) is pleased to announce the voting results of its annual and special meeting (the "Meeting") of the holders of its common shares ("Common Shares") held on September 15, 2020. At the Meeting, Shareholders approved a special resolution (the "Arrangement Resolution") in respect of a statutory plan of arrangement (the "Arrangement") under the Business Corporations APacgen Announces Proposed Acquisition by General Biologicals Corporation
VANCOUVER, British Columbia, July 07, 2020 (GLOBE NEWSWIRE) -- Pacgen Life Science Corporation (“Pacgen” or the “Company”) (TSX-V: PBS) announced today that it has reached a definitive agreement pursuant to which General Biologicals Corporation (“GBC”), a Taiwan-based diagnostic and pharmaceutical company, will acquire the issued and outstanding shares of Pacgen in an all cash transaction.
Read more news
Top Healthcare Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding General Biologicals
Sign Up For FreeTo access detailed company insights
Founded in 1984, General Biologicals Corporation (GBC) is a Taiwanese leader in precision diagnostics and biotechnology, specializing in in-vitro diagnostics (IVD) and next-generation therapeutics. GBC offers a diverse range of products, including liquid biopsy systems, antimicrobial peptide therapies, and digital healthcare solutions, serving hosp... Read More
